Impact of long-term statin pretreatment on myocardial damage in St elevation myocardial infarction (from the AIDA STEMI CMR substudy)

American Journal of Cardiology

Volumn 114, Issue 4, 2014, Pages 503-509

  Fuernau, Georg ^a   Eitel, Ingo ^a   Wöhrle, Jochen ^b   Kerber, Sebastian ^c   Lauer, Bernward ^d   Pauschinger, Matthias ^e   Schwab, Johannes ^e   Birkemeyer, Ralf ^f   Pfeiffer, Stefan ^g   Mende, Meinhard ^a   Brosteanu, Oana ^a   Neuhaus, Petra ^a   Desch, Steffen ^a,h   De Waha, Suzanne ^a,i   Gutberlet, Matthias ^a   Schuler, Gerhard ^a   Thiele, Holger ^a,h  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c Cardiovascular Clinic Bad Neustadt   (Germany)

^d Department of Cardiology Herz und Gefäß Klinik Bad Neustadt ^*  (Germany)

^e KLINIKUM NÜRNBERG   (Germany)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g Klinikum Pforzheim GmbH   (Germany)

^h UNIVERSITY OF LÜBECK   (Germany)

ⁱ Segeberger Kliniken   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AREA AT RISK; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR SYMPTOM; CLINICAL ASSESSMENT TOOL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR OBSTRUCTION; MULTICENTER STUDY; MYOCARDIAL SALVAGE INDEX; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SHORT COURSE THERAPY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905585676     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.05.026     Document Type: Article

References (27)

1. A.M. Beek, and A.C. van Rossum Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction Heart 96 2010 237 243
2. M.G. Friedrich, H. Abdel-Aty, A. Taylor, J. Schulz-Menger, D. Messroghli, and R. Dietz The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1581 1587
3. S. de Waha, S. Desch, I. Eitel, G. Fuernau, J. Zachrau, A. Leuschner, M. Gutberlet, G. Schuler, and H. Thiele Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers Eur Heart J 31 2010 2660 2668
4. S. Desch, I. Eitel, S. de Waha, G. Fuernau, P. Lurz, M. Gutberlet, G. Schuler, and H. Thiele Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction Trials 12 2011 204
5. I. Eitel, S. Desch, G. Fuernau, L. Hildebrand, M. Gutberlet, G. Schuler, and H. Thiele Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction J Am Coll Cardiol 55 2010 2470 2479
6. G. Fuernau, I. Eitel, V. Franke, L. Hildebrandt, J. Meissner, S. de Waha, P. Lurz, M. Gutberlet, S. Desch, G. Schuler, and H. Thiele Myocardium at risk in ST-segment elevation myocardial infarction comparison of T2-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring JACC Cardiovasc Imaging 4 2011 967 976
7. H. Thiele, J. Wohrle, R. Hambrecht, H. Rittger, R. Birkemeyer, B. Lauer, P. Neuhaus, O. Brosteanu, P. Sick, M. Wiemer, S. Kerber, K. Kleinertz, I. Eitel, S. Desch, and G. Schuler Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial Lancet 379 2012 923 931
8. H. Thiele, J. Wohrle, P. Neuhaus, O. Brosteanu, P. Sick, R. Prondzinsky, R. Birkemeyer, M. Wiemer, S. Kerber, H. Schuehlen, K. Kleinertz, C. Axthelm, R. Zimmermann, H. Rittger, R.C. Braun-Dullaeus, B. Lauer, W. Burckhardt, M. Ferrari, M.W. Bergmann, R. Hambrecht, and G. Schuler Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial Am Heart J 159 2010 547 554
9. S. Desch, J. Wohrle, R. Hambrecht, H. Rittger, R. Birkemeyer, B. Lauer, P. Neuhaus, O. Brosteanu, P. Sick, M. Pauschinger, S. Kerber, K. Kleinertz, W.S. de, I. Eitel, G. Schuler, and H. Thiele Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial J Am Coll Cardiol 62 2013 1214 1215
10. I. Eitel, J. Wohrle, H. Suenkel, J. Meissner, S. Kerber, B. Lauer, M. Pauschinger, R. Birkemeyer, C. Axthelm, R. Zimmermann, P. Neuhaus, O. Brosteanu, S. de Waha, S. Desch, M. Gutberlet, G. Schuler, and H. Thiele Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial J Am Coll Cardiol 61 2013 1447 1454
11. H. Thiele, M.J. Kappl, S. Conradi, J. Niebauer, R. Hambrecht, and G. Schuler Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging J Am Coll Cardiol 47 2006 1641 1645
12. S. Desch, H. Engelhardt, J. Meissner, I. Eitel, M. Sareban, G. Fuernau, S. de Waha, M. Grothoff, M. Gutberlet, G. Schuler, and H. Thiele Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction Int J Cardiovasc Imaging 28 2011 263 272
13. H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, D. Kivelitz, and G. Schuler Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
14. Z. Reiner, A.L. Catapano, B.G. De, I. Graham, M.R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M.J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P.P. Filardi, G. Riccardi, R.F. Storey, and D. Wood ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
15. P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blomstrom-Lundqvist, M.A. Borger, M.C. Di, K. Dickstein, G. Ducrocq, F. Fernandez-Aviles, A.H. Gershlick, P. Giannuzzi, S. Halvorsen, K. Huber, P. Juni, A. Kastrati, J. Knuuti, M.J. Lenzen, K.W. Mahaffey, M. Valgimigli, H.A. van 't, P. Widimsky, and D. Zahger ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
16. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, and D.X. Zhao 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines J Am Coll Cardiol 61 2013 e78 e140
17. S.C. Smith Jr., E.J. Benjamin, R.O. Bonow, L.T. Braun, M.A. Creager, B.A. Franklin, R.J. Gibbons, S.M. Grundy, L.F. Hiratzka, D.W. Jones, D.M. Lloyd-Jones, M. Minissian, L. Mosca, E.D. Peterson, R.L. Sacco, J. Spertus, J.H. Stein, and K.A. Taubert AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association J Am Coll Cardiol 58 2011 2432 2446
18. K.H. Lee, M.H. Jeong, H.M. Kim, Y. Ahn, J.H. Kim, S.C. Chae, Y.J. Kim, S.H. Hur, I.W. Seong, T.J. Hong, D.H. Choi, M.C. Cho, C.J. Kim, K.B. Seung, W.S. Chung, Y.S. Jang, S.W. Rha, J.H. Bae, J.G. Cho, and S.J. Park Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol J Am Coll Cardiol 58 2011 1664 1671
19. V. Oduncu, A.C. Tanalp, A. Erkol, D. Sirma, C. Dundar, T. Akgun, E. Turkyilmaz, A. Kilicgedik, G. Gozubuyuk, K. Tigen, A. Izgi, and C. Kirma Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty Am J Cardiol 107 2011 179 185
20. K. Iwakura, H. Ito, S. Kawano, A. Okamura, T. Kurotobi, M. Date, K. Inoue, and K. Fujii Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction Eur Heart J 27 2006 534 539
21. T. Bauer, M. Bohm, R. Zahn, C. Junger, O. Koeth, A. Gitt, K. Bestehorn, J. Senges, and U. Zeymer Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction J Cardiovasc Pharmacol 53 2009 132 136
22. P. Garot, N. Bendaoud, T. Lefevre, and M.C. Morice Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock Euro Intervention 6 2010 350 355
23. M. Pastuszczak, A. Kotlarz, M. Mostowik, J. Zalewski, K. Zmudka, and A. Undas Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction Thromb Res 125 2010 382 386
24. X.D. Li, Y.J. Yang, Y.J. Geng, Y.T. Cheng, H.T. Zhang, J.L. Zhao, J.Q. Yuan, and R.L. Gao The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway Int J Cardiol 167 2013 2657 2666
25. E.I. Lev, R. Kornowski, H. Vaknin-Assa, I. Ben-Dor, D. Brosh, I. Teplitsky, S. Fuchs, A. Battler, and A. Assali Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol 103 2009 165 169
26. E.O. Weinberg, M. Scherrer-Crosbie, M.H. Picard, B.A. Nasseri, C. MacGillivray, J. Gannon, Q. Lian, K.D. Bloch, and R.T. Lee Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion Am J Physiol Heart Circ Physiol 288 2005 H1802 H1809
27. F. Angeli, G. Reboldi, G. Mazzotta, M. Garofoli, M.F. Cerasa, and P. Verdecchia Statins in acute coronary syndrome: very early initiation and benefits Ther Adv Cardiovasc Dis 6 2012 163 174